{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:41:50Z","timestamp":1792662110641,"version":"4.5.0"},"reference-count":60,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"accepted":{"date-parts":[[2026,1,30]]},"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1136\/bjo-2025-329103","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T18:20:23Z","timestamp":1772734823000},"page":"1312-1318","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment failure in herpes simplex virus type 1 keratitis"],"prefix":"10.1136","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6993-291X","authenticated-orcid":false,"given":"Anna C","family":"Randag","sequence":"first","affiliation":[{"name":"Cornea and External Diseases Department, Rotterdam Eye Hospital, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges MGM","family":"Verjans","sequence":"additional","affiliation":[{"name":"HerpeslabNL of the Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2213-1576","authenticated-orcid":false,"given":"Lies","family":"Remeijer","sequence":"additional","affiliation":[{"name":"Cornea and External Diseases Department, Rotterdam Eye Hospital, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"2026102202150872000_110.11.1312.1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.19.237149"},{"key":"2026102202150872000_110.11.1312.2","doi-asserted-by":"publisher","DOI":"10.1080\/09286586.2021.1962919"},{"key":"2026102202150872000_110.11.1312.3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ophtha.2016.10.001","article-title":"Persistent Impairment of Quality of Life in Patients with Herpes Simplex Keratitis","volume":"124","author":"Reynaud","year":"2017","journal-title":"Ophthalmology"},{"key":"2026102202150872000_110.11.1312.4","article-title":"Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis","volume":"1","author":"Wilhelmus","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026102202150872000_110.11.1312.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.03.031"},{"key":"2026102202150872000_110.11.1312.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2018.10.002"},{"key":"2026102202150872000_110.11.1312.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(94)31087-6"},{"key":"2026102202150872000_110.11.1312.8","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ophtha.2019.09.044","article-title":"The Herpetic Eye Disease Study: Topical Corticosteroid Trial for Herpes Simplex Stromal Keratitis: A Paradigm Shifting Clinical Trial","volume":"127","author":"Chodosh","year":"2020","journal-title":"Ophthalmology"},{"key":"2026102202150872000_110.11.1312.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807303390503"},{"key":"2026102202150872000_110.11.1312.10","first-page":"281","article-title":"Basic Clinical Science Course","volume":"8","author":"Feder","year":"2022","journal-title":"American Academy of Ophthalmology"},{"key":"2026102202150872000_110.11.1312.11","doi-asserted-by":"publisher","DOI":"10.1086\/590668"},{"key":"2026102202150872000_110.11.1312.12","doi-asserted-by":"publisher","DOI":"10.1086\/606028"},{"key":"2026102202150872000_110.11.1312.13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1442-9071.2010.02209.x","article-title":"Aciclovir-resistant herpes keratitis","volume":"38","author":"Choong","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"key":"2026102202150872000_110.11.1312.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.09.013"},{"key":"2026102202150872000_110.11.1312.15","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit350"},{"key":"2026102202150872000_110.11.1312.16","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.12785"},{"key":"2026102202150872000_110.11.1312.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.12.002"},{"key":"2026102202150872000_110.11.1312.18","doi-asserted-by":"publisher","DOI":"10.1086\/517382"},{"key":"2026102202150872000_110.11.1312.19","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1983.01040010913011"},{"key":"2026102202150872000_110.11.1312.20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/02713688709020088","article-title":"Clinical aspects of herpetic eye diseases","volume":"6","author":"Sundmacher","year":"1987","journal-title":"Curr Eye Res"},{"key":"2026102202150872000_110.11.1312.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.04.022"},{"key":"2026102202150872000_110.11.1312.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2016.01.010"},{"key":"2026102202150872000_110.11.1312.23","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200101000-00001"},{"key":"2026102202150872000_110.11.1312.24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222092","article-title":"The rising incidence of Acanthamoeba keratitis: A 7-year nationwide survey and clinical assessment of risk factors and functional outcomes","volume":"14","author":"Randag","year":"2019","journal-title":"PLoS One"},{"key":"2026102202150872000_110.11.1312.25","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s15010-022-01857-0","article-title":"Acanthamoeba more commonly causes epithelial keratitis than herpes simplex in South-East England contact lens users","volume":"50","author":"Sanchez","year":"2022","journal-title":"Infection"},{"key":"2026102202150872000_110.11.1312.26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.sjopt.2011.10.001","article-title":"Cytomegalovirus-related corneal endotheliitis: A review article","volume":"27","author":"Alfawaz","year":"2013","journal-title":"Saudi J Ophthalmol"},{"key":"2026102202150872000_110.11.1312.27","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00615-10"},{"key":"2026102202150872000_110.11.1312.28","doi-asserted-by":"publisher","DOI":"10.1007\/BF01963751"},{"key":"2026102202150872000_110.11.1312.29","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/veaa013","article-title":"In vitro evolution of herpes simplex virus 1 (HSV-1) reveals selection for syncytia and other minor variants in cell culture","volume":"6","author":"Kuny","year":"2020","journal-title":"Virus Evol"},{"key":"2026102202150872000_110.11.1312.30","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.cmi.2025.04.046","article-title":"Herpes simplex virus and drug resistance-comprehensive update on resistance mutations and implications for clinical management: a narrative review","volume":"31","author":"D\u00e4hne","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"2026102202150872000_110.11.1312.31","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.00941","article-title":"Alpha-Herpesvirus Thymidine Kinase Genes Mediate Viral Virulence and Are Potential Therapeutic Targets","volume":"10","author":"Xie","year":"2019","journal-title":"Front Microbiol"},{"key":"2026102202150872000_110.11.1312.32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00155-06"},{"key":"2026102202150872000_110.11.1312.33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.12.4736"},{"key":"2026102202150872000_110.11.1312.34","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.82223-0"},{"key":"2026102202150872000_110.11.1312.35","first-page":"329","article-title":"Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections","volume":"23","author":"Carmine","year":"1982","journal-title":"Drugs (Abingdon Engl)"},{"key":"2026102202150872000_110.11.1312.36","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1177\/09564624211006568","article-title":"Use of pritelivir in refractory aciclovir-resistant herpes simplex virus type 2","volume":"32","author":"Cannon","year":"2021","journal-title":"Int J STD AIDS"},{"key":"2026102202150872000_110.11.1312.37","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/jac\/dkac165","article-title":"Pritelivir for recurrent aciclovir-resistant herpes simplex virus 2 infections in immunocompromised patients","volume":"77","author":"Serris","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2026102202150872000_110.11.1312.38","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13948"},{"key":"2026102202150872000_110.11.1312.39","doi-asserted-by":"crossref","first-page":"104433","DOI":"10.1016\/j.jfo.2025.104433","article-title":"Pathophysiology and treatment of acyclovir-resistant herpes simplex virus keratitis","volume":"48","author":"Boucher","year":"2025","journal-title":"J Fr Ophtalmol"},{"key":"2026102202150872000_110.11.1312.40","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1982.01030040944016"},{"key":"2026102202150872000_110.11.1312.41","first-page":"365","article-title":"Intraocular penetration of topically administered acyclovir","volume":"6","author":"Kitagawa","year":"1989","journal-title":"Lens Eye Toxic Res"},{"key":"2026102202150872000_110.11.1312.42","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-308238"},{"key":"2026102202150872000_110.11.1312.43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191850","article-title":"Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: A pilot study","volume":"13","author":"Waduthantri","year":"2018","journal-title":"PLoS One"},{"key":"2026102202150872000_110.11.1312.44","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9394(79)90360-X","article-title":"Intraocular penetration of trifluridine","volume":"87","author":"Pavan-Langston","year":"1979","journal-title":"Am J Ophthalmol"},{"key":"2026102202150872000_110.11.1312.45","unstructured":"White ML , Chodosh J . Herpes simplex virus keratitis: a treatment guideline. 2014."},{"key":"2026102202150872000_110.11.1312.46","first-page":"14","article-title":"The pharmacological profile of famciclovir","volume":"15","author":"Crumpacker","year":"1996","journal-title":"Semin Dermatol"},{"key":"2026102202150872000_110.11.1312.47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajoc.2022.101268","article-title":"Putting drug resistant epithelial herpes keratitis in the spotlight: A case series","volume":"25","author":"De Clerck","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"2026102202150872000_110.11.1312.48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108223250805"},{"key":"2026102202150872000_110.11.1312.49","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1994.10.439"},{"key":"2026102202150872000_110.11.1312.50","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.68.3.192"},{"key":"2026102202150872000_110.11.1312.51","unstructured":"Harding S . Superior intraocular penetration of aciclovir after valaciclovir in comparison with oral aciclovir. Abstracts of Interscience conference on antimicrobial agents; Session 69A, Paper A-45; 1998"},{"key":"2026102202150872000_110.11.1312.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.11.016"},{"key":"2026102202150872000_110.11.1312.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.02.010"},{"key":"2026102202150872000_110.11.1312.54","first-page":"116","article-title":"Intraocular penetration of new antiviral agent, hydroxyacyclovir (BW-B759U)","volume":"30","author":"Schulman","year":"1986","journal-title":"Jpn J Ophthalmol"},{"key":"2026102202150872000_110.11.1312.55","first-page":"532","article-title":"Trifluorothymidine treatment of herpetic iritis in rabbits and ocular penetration","volume":"12","author":"Sugar","year":"1973","journal-title":"Invest Ophthalmol"},{"key":"2026102202150872000_110.11.1312.56","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/eye.1990.70","article-title":"Penetration of synthetic corticosteroids into human aqueous humour","volume":"4 (Pt 3)","author":"McGhee","year":"1990","journal-title":"Eye (Lond)"},{"key":"2026102202150872000_110.11.1312.57","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0002-9394(77)90740-1","article-title":"Penetration of topically administered prednisolone acetate into the human aqueous humor","volume":"83","author":"Leibowitz","year":"1977","journal-title":"Am J Ophthalmol"},{"key":"2026102202150872000_110.11.1312.58","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/eye.1989.69","article-title":"Penetration of topically applied prednisolone sodium phosphate into human aqueous humour","volume":"3 (Pt 4)","author":"McGhee","year":"1989","journal-title":"Eye (Lond)"},{"key":"2026102202150872000_110.11.1312.59","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1988.01060130748037"},{"key":"2026102202150872000_110.11.1312.60","first-page":"1199","article-title":"Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans","volume":"37","author":"Kristinsson","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2025-329103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:16:32Z","timestamp":1792660592000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2025-329103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":60,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,10,22]]},"published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1136\/bjo-2025-329103"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2025-329103","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]}}}